Gout
📧 Sign up to get email alerts when something new happens for Gout.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-01-25Clinical Trial Update: DECT Study in Allopurinol-Treated Gout Patients
Completed DECT imaging study in gout patients treated with allopurinol; the available snippet does not report results.
-
CLINICAL_TRIALS trial_result · 2017-01-24Clinical Trial Update: Lesinurad and Allopurinol Combination Extension Study in Gout [Phase 3]
This document reports the completion of a Phase 3 extension trial evaluating the combination of lesinurad with allopurinol for gout.
-
CLINICAL_TRIALS trial_result · 2017-01-24Clinical Trial Update: Allopurinol Combination Study [Phase 2]
Phase 2 trial evaluating an allopurinol-based combination therapy for gout has completed.
-
FDA approval · 2017-01-23FDA Approved: NAPROXEN — Original Application (Amerisource Bergen)
FDA approves AmerisourceBergen's original application for naproxen sodium tablets, a generic naproxen product.
-
CLINICAL_TRIALS trial_result · 2017-01-13Clinical Trial Update: Effects of Hyperuricemia Reversal on Features of the Metabolic Syndrome [Phase 4]
Phase 4 clinical trial evaluating whether reversal of hyperuricemia affects features of metabolic syndrome in gout patients; results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-01-10Clinical Trial Update: Study of URC102 to Assess the Safety and Efficacy in Gout Patients [Phase 2]
A Phase 2 study of URC102 by JW Pharmaceutical evaluated safety and efficacy in patients with gout and hyperuricemia. The trial has complete…
-
CLINICAL_TRIALS trial_result · 2017-01-05Clinical Trial Update: Arthritis Research UK Gout Treatment Trial - Phase 2 [NA]
A Phase 2 gout treatment clinical trial conducted by Arthritis Research UK has completed; no results are provided in the update.
-
FDA approval · 2016-12-22FDA Approved: COLCRYS — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for COLCRYS (colchicine) from Takeda Pharmaceuticals America, Inc., indicating changes to its labeli…
-
CLINICAL_TRIALS trial_result · 2016-11-11Clinical Trial Update: Efficacy, Safety And Tolerability Of PF-06743649 In Gout Subjects. [Phase 1]
Phase 1 study of PF-06743649 in gout patients was terminated; results evaluating efficacy, safety, and tolerability were posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-11-03Clinical Trial Update: Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout and Moderate Renal Impairment [Phase 2]
A Phase 2 trial evaluating the efficacy and safety of extended-release and immediate-release febuxostat in patients with gout and moderate r…
-
CLINICAL_TRIALS trial_result · 2016-11-03Clinical Trial Update: Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout [Phase 3]
Phase 3 trial comparing extended-release and immediate-release febuxostat in gout patients evaluated efficacy and safety outcomes.
-
CLINICAL_TRIALS trial_result · 2016-10-21Clinical Trial Update: Safety and Pharmacodynamics of SEL-037 (Pegsiticase) in Subjects With Elevated Blood Uric Acid Levels [Phase 1]
Phase 1 study evaluating the safety and pharmacodynamics of SEL-037 (Pegsiticase) in patients with gout and elevated uric acid; the trial ha…
-
CLINICAL_TRIALS research · 2016-10-21Clinical Trial Update: Role of ASICs in Human Inflammatory Pain
The update covers research on the role of acid-sensing ion channels (ASICs) in human inflammatory pain. It lists several inflammatory diseas…
-
CLINICAL_TRIALS trial_result · 2016-10-05Clinical Trial Update: Bucillamine for the Treatment of Acute Gout Flare in Subjects With Moderate to Severe Gout [Phase 2]
Phase 2 clinical trial evaluating Bucillamine for acute gout flares in patients with moderate to severe gout has completed.
-
CLINICAL_TRIALS trial_result · 2016-09-13Clinical Trial Update: Optimal Administration of Allopurinol in Dialysis Patients [Phase 4]
Phase 4 clinical trial evaluating the optimal administration of allopurinol in dialysis patients has completed.
-
FDA approval · 2016-09-09FDA Approved: KRYSTEXXA — Supplemental Application (Horizon Therapeutics USA, Inc.)
FDA approved a supplemental application for KRYSTEXXA (pegloticase) submitted by Horizon Therapeutics USA, Inc., representing an additional …
-
FDA approval · 2016-09-09FDA Approved: ALLOPURINOL SODIUM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Allopurinol Sodium (generic) from Hikma Pharmaceuticals USA Inc. under an ANDA.
-
CLINICAL_TRIALS trial_result · 2016-09-02Clinical Trial Update: RDEA3170 PK/PD Study [Phase 1]
Phase 1 PK/PD study of RDEA3170 for gout has completed.
-
CLINICAL_TRIALS trial_result · 2016-08-30Clinical Trial Update: Purine Metabolism Enzyme SNP to Uric Acid Production
A clinical trial evaluating the link between a purine metabolism enzyme SNP and uric acid production in gout and hyperuricemia has completed…
-
CLINICAL_TRIALS research · 2016-08-24Clinical Trial Update: Meta-analyses of Impotrant Food Sources of Sugars and Incident Cardiometabolic Diseases
An update describing meta-analyses on how different dietary sugar sources relate to the development of cardiometabolic diseases. The analyse…
-
CLINICAL_TRIALS trial_result · 2016-08-18Clinical Trial Update: Combining Lesinurad With Allopurinol in Inadequate Responders [Phase 3]
A Phase 3 trial evaluated adding lesinurad to allopurinol in gout patients who did not respond adequately, with results posted in 2016.
-
FDA approval · 2016-07-28FDA Approved: ALLOPURINOL — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved an original (generic) application for allopurinol from Heritage Pharmaceuticals Inc. (d/b/a Avet Pharmaceuticals Inc.).
-
EMA withdrawal · 2016-07-22EMA Withdrawn: Krystexxa (pegloticase) — Crealta Pharmaceuticals Ireland Limited
EMA withdrew Krystexxa (pegloticase) from the market for gout.
-
CLINICAL_TRIALS trial_result · 2016-06-20Clinical Trial Update: Efficacy and Safety of HuZhen Capsule for Treatment of Patients With Acute Gout [Phase 3]
Phase 3 trial assessing the efficacy and safety of HuZhen Capsule for acute gout; no results are provided in this update.
-
CLINICAL_TRIALS trial_result · 2016-05-30Clinical Trial Update: Postmarketing Study to Determine Performance of the SIGMA HP® PARTIAL KNEE SYSTEM [Phase 4]
Phase 4 postmarketing study to evaluate the performance of the SIGMA HP Partial Knee System. The study status is COMPLETED.